“REVIEW ON OCD: INTRODUCTION, CLINICAL PRESENTATION, EPIDEMIOLOGY, CASE PRESENTATION, RISK FACTORS, PSYCHOTHERAPY.”
Main Article Content
Keywords
Obsessive compulsive disorder (OCD), Obsession, Compulsions, Serotonin, Serotonin, serotonin-reuptake inhibitors (SSRI’S)
Abstract
Obsessive-compulsive disorder (OCD)is a common psychiatric disordercharacterized by obsession and compulsions. The WHOhas classified OCD asone of the 10 most handicapping condition by lost income and decreased quality of life. OCD once was believed a rare disorder, but epidemiologic studies revealed it affected between 2% and 3% of total world-wide population. Although several effective treatments are currently available for OCD that will be psychiatric or pharmacological, most patients do not seek treatment until the disorder is seriously affecting their lives. Cognitive behavioral psychotherapy (CBT) is the psychotherapy/ treatment for children, juvenile and grownups with OCD. CBT helps create an internal tactic for battling OCD that will give lifelong benefit for the patient. Individuals respond differently to psychotherapy, fair as they do to medication. CBT is moderately free of side-effects, but all patients possess some anxiety throughout treatment.
References
2. Wikipedia.obsessive-compulsive disorder. {online}. https://en.m.wikipedia.org/wiki /obsessive%E2%80%93compulsive-disorder. Retrieved on 01-jan-2024.
3. Google scholar. OCD. Suicidality in obsessive compulsive disorder [OCD]: a systematic review and meta-analysis. {online}. https://www.sciencedirect.com/science/article /abs/pii/S0272735815000434.
4. The National Institute of Mental Health (NIMH) (January 2016). “Whatis obsessive-compulsive disorder (OCD)?” {online}. https://www.nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd.
5. Diagnostic and statistical manual of mental disorder. Fifth edition. DSM 5. American psychiatric publishing 2013.
6. Alevizos B, Papageorgiou C, Christodoulou GN (September 2004). "Obsessive-compulsive symptoms with olanzapine". The International Journal of Neuropsychopharmacology. Page no.: 375–377.
7. Kulkarni G, Narayanaswamy JC, Math SB (1 January 2012). "Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia". Indian Journal of Pharmacology. Page no.: 649–650. Robbins, T. W., Vaghi, M. M. & Banca, P. Obsessive-compulsive disorder: puzzles and prospects. Neuron 102, 27–47 (2019).
8. Bloch, M. H., Landeros-Weisenberger, A., Rosario, M. C., Pittenger, C. & Leckman, J. F. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am. J. Psychiatry 165, 1532–1542 (2008).{online}. https://www.cell.com/neuron/fulltext/S0896-6273(19)30073-X?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS089662731930073X%3Fshowall%3Dtrue
9. Stein, D. J., Hollander, E. & Josephson, S. C. Serotonin reuptake blockers for the treatment of obsessional jealousy. J. Clin. Psychiatry 55, 30–33 (1994). {online} https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2008.08020320
10. Monzani, B., Rijsdijk, F., Harris, J. &Mataix-Cols, D. The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders. JAMA Psychiatry 71, 182–189 (2014).
11. Ruscio, A. M., Stein, D. J., Chiu, W. T. & Kessler, R. C. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol. Psychiatry 15, 53–63 (2008). This community survey provides data on the prevalence and comorbidity of OCD in the general population.https://jamanetwork.com/journals /jamapsychiatry/fullarticle/1792141
12. Brander, G., Pérez-Vigil, A., Larsson, H. &Mataix-Cols, D. Systematic review of environmental risk factors for obsessive-compulsive disorder: a proposed roadmap from association to causation. Neurosci. Biobehav. Rev. 65, 36–62 (2016).https://www.nature.com/ articles/mp200894
13. Dykshoorn, K. L. Trauma-related obsessive–compulsive disorder: a review. Health Psychol. Behav. Med. 2, 517–528 (2014).https://www.sciencedirect.com/science/article/ abs/pii/S0149763415302293?via%3Dihub
14. Salkovskis, P. M. Obsessional-compulsive problems: a cognitive-behavioural analysis. Behav. Res. Ther. 23, 571–583 (1985).https://www.tandfonline.com/doi/full/10.1080/2164 2850.2014.905207
15. Benzina, N., Mallet, L., Burguière, E., N’Diaye, K. &Pelissolo, A. Cognitive dysfunction in obsessive-compulsive disorder. Curr. Psychiatry Rep. 18, 80 (2016).https://www.sciencedirect.com/science/article/abs/pii/0005796785901056?via%3Dihub
16. Goodman, W. K. et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch. Gen. Psychiatry 46, 1006–1011 (1989). The Y-BOCS remains the gold standard measure for assessing symptom severity in OCD.https://link.springer.com /article/10.1007/s11920-016-0720-3
17. Rosario-Campos, M. C. et al. The Dimensional Yale–Brown Obsessive–Compulsive Scale (DY-BOCS): an instrument for assessing obsessive–compulsive symptom dimensions. Mol. Psychiatry 11, 495–504 (2006).https://jamanetwork.com/journals/jamapsychiatry/article-abstract/494743
18. Huppert, J. D. & Franklin, M. E. Cognitive behavioural therapy for obsessive-compulsive disorder: an update. Curr. Psychiatry Rep. 7, 268–273 (2005).https://www.nature. com/articles/4001798
19. Huppert, J. D. & Franklin, M. E. Cognitive behavioural therapy for obsessive-compulsive disorder: an update. Curr. Psychiatry Rep. 7, 268–273 (2005). {online}. https://link.springer.com/article/10.1007/s11920-005-0080-x
20. Hirschtritt, M. E., Bloch, M. H. & Mathews, C. A. Obsessive-compulsive disorder. JAMA 317, 1358 (2017). {online}. https://jamanetwork.com/journals/jama/article-abstract/2614194
21. Wootton, B. M. Remote cognitive–behaviour therapy for obsessive–compulsive symptoms: a meta-analysis. Clin. Psychol. Rev. 43, 103–113 (2016). {online}. https://www.sciencedirect.com/science/article/abs/pii/S0272735815001361?via%3Dihub
22. Skapinakis, P. et al. Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry 3, 730–739 (2016). {online}.https://www.thelancet.com/journals /lanpsy/article/PIIS2215-0366(16)30069-4/fulltext
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Syed Zakir
Departmentof Pharmacy Practice (Student), Adesh institute of Pharmacy and Biomedical sciences, Adesh University, Bathinda,
Tabish Nisar
Departmentof Pharmacy Practice (Student), Adesh institute of Pharmacy and Biomedical sciences, Adesh University, Bathinda,
Santosh Kumar Tripathi
Professor and Clinical Psychologist, Department of Psychiatry, Adesh Institute of Medical sciences and Research, Adesh University, Bathinda.
Rajesh Kumari Patil
Professor, Department of Pharmacy Practice, Adesh Institute of Pharmacy and Biomedical sciences, Adesh University, Bathinda,